Digestive Diseases and Microbiota
Basic/translational research
Modify by Institut d'Investigació Biomèdica de Girona (IDIBGI) - H. Universitari Dr. Josep Trueta
·Girona ·

The group Malalties Digestives i Microbiota of IDIBGI focuses on studying the etiology of digestive diseases and the role of risk factors related to lifestyle and the role of microorganisms living in the intestine. It comprises a multidisciplinary team with basic and clinical researchers. The methodology employed includes observational studies at the phenotypic and molecular level, and instrumental studies to test causality.

Main publications in pancreatic cancer:

  1. Carreras-Torres R, johansson M, Gaborieau V, et al. The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study. J Natl Cancer Inst. 2017 Sep 1;109(9):djx012. doi: 10.1093/jnci/djx012.
  2. Hatcher C, Richenberg G, Waterson S, et al. Application of Mendelian randomization to explore the causal role of the human gut microbiome in colorectal cancer. Sci Rep. 2023 Apr 12;13(1):5968. doi: 10.1038/s41598-023-31840-0.
  3. Bossé Y, Li Z, Xia J, et al. Transcriptome-wide association study reveals candidate causal genes for lung cancer. Int J Cancer. 2020 Apr 1;146(7):1862-1878. doi: 10.1002/ijc.32771.
Robert Carreras

Principal Investigator

Group members

  • Robert Carreras
  • Xavier Aldeguer
  • Jesús García-Gil
  • Esther Fort
  • Laura Pardo
More information

Other groups

Glycoimmunology Laboratory – Gabriel Rabinovich

The Glycoimmunology Laboratory, led by Dr. Gabriel Rabinovich and currently based at the CaixaResearch Institute (Barcelona), investigates immunoregulatory circuits mediated by lectinin a wide variety of pathological contexts, including cancer, autoimmune diseases,...

Virology and Cellular Immunology Group – Carmen Aguilar

Our group at IrsiCaixa focuses on the development of innovative therapeutic strategies against solid tumors, with a particular emphasis on pancreatic cancer. The group integrates immunological, molecular, and translational approaches to design and evaluate cancer...

Neoantigens and Vaccines Against Cancer – Núria de la Iglesia

The Neoantigens and Cancer Vaccines group (NeoVaCan) is part of the IrsiCaixa Institute for Research on Immunopathologies, a center dedicated to the study of diseasesrelated to the immune system, ranging from viral infections, such as HIV or SARS-CoV-2, to cancer. Our...

See all groups